Logotype for Clariant AG

Clariant (CLN) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Clariant AG

Q2 2025 earnings summary

21 Aug, 2026

Executive summary

  • Q2 2025 sales were CHF 968 million, flat in local currency but down 8% in CHF due to FX; H1 2025 sales reached CHF 1.981 billion, up 1% in local currency but down 4% in CHF, with growth in Catalysts and Adsorbents & Additives offsetting a slight decline in Care Chemicals.

  • Q2 2025 EBITDA before exceptionals rose 3% to CHF 169 million (17.5% margin, up 200 bps YoY), driven by Catalysts and Adsorbents & Additives; H1 EBITDA before exceptionals was CHF 359 million (18.1% margin, up 130 bps YoY).

  • Net income for H1 2025 dropped to CHF 44 million from CHF 176 million prior year, mainly due to CHF 60 million restructuring charges and CHF 30 million impairments.

  • Free cash flow conversion improved to 37% (LTM), with H1 operating cash flow at CHF 116 million.

  • CHF 80 million savings program underway, with CHF 12 million achieved in H1 2025; significant restructuring, impairment, and exceptional expenses recorded.

Financial highlights

  • Q2 2025 EBITDA before exceptionals increased 3% YoY to CHF 169 million (17.5% margin, up 200 bps); H1 EBITDA before exceptionals CHF 359 million (18.1% margin, up 130 bps).

  • Reported EBITDA for H1 2025 was CHF 291 million (-14% YoY) due to restructuring charges; net income CHF 44 million.

  • Gross margin for H1 2025 was 29.6%, down from 30.7% prior year.

  • Net debt increased to CHF 1.596 billion, with net debt/EBITDA at 2.6x (2.4x before exceptionals).

  • Basic EPS fell to CHF 0.08 from CHF 0.48 year-over-year.

Outlook and guidance

  • 2025 sales growth guidance revised to 1–3% in local currency due to weak industrial production and market uncertainty.

  • EBITDA margin before exceptionals confirmed at 17–18% for 2025; reported margin expected at 15.0–15.5%.

  • Medium-term targets: 4–6% CAGR sales growth, 19–21% EBITDA margin, and ~40% FCF conversion by 2027.

  • Capex targeted at CHF 200 million for 2025; CHF 75 million restructuring charges expected.

  • Ongoing macroeconomic uncertainties and trade tensions expected to weigh on demand and volumes.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more